Empowering solutions in Medical Affairs
There has recently been a major refocus on the function of Medical Affairs in the pharmaceutical industry. However, the scope of abilities and responsibilities within Medical Affairs teams remains unclear – as a result, Medical Affairs initiatives are currently limited to providing information to healthcare professionals (HCPs) through various educational campaigns.
The potential of Medical Affairs extends far beyond this!
- Medical Affairs teams are uniquely positioned to address a number of modern challenges, such as:
- The increasing complexity of novel therapeutics, including their mechanisms of action
- The overwhelming intricacy of evidence generation, through innovative clinical trial designs that make the interpretation of data and communication of those interpretations even more challenging
- The information overload that HCPs face from all angles, which makes it difficult to identify the most valuable and impactful pieces of data
- The evolving landscape of industry interactions with HCPs and other stakeholders, where regulations often obstruct the efforts of commercial branches to deliver the essentials in a timely and effective manner
The solutions lie in empowering Medical Affairs teams to lead and resolve:
- Timing of engagement. Medical Affairs teams can be tasked with responsibilities ranging from early pre-launch (18–36 months before approval) to peri- and post-launch stakeholder engagement
- Scoping stakeholders. Medical Affairs teams are uniquely positioned to interact with HCPs, key thought leaders, regulatory and reimbursement bodies, patient advocacy groups and many others
- Data generation. Medical Affairs professionals are empowered to engage in data generation – from contributing to pivotal studies to post-marketing research (collaborative and external investigator-initiated programs) to data dissemination (both company-driven satellite symposia, standalones, etc., as well as independently managed CME initiatives) and additional data interpretation and analysis
- Communication. Medical Affairs ensure two-way communication with various stakeholders through the management of advisory boards, steering committees, 1:1 interactions and other sources of reactive medical information
- Ultimately, Medical Affairs have the potential to lead strategic decision-making
Optimising pharmaceutical strategies and workflows is a tough endeavour; partnering with other experienced professionals in the industry – such as the Medical Affairs team at Cognite – offers a swift, straightforward, effective and rewarding approach.
If you have any questions or would like to hear more from our Medical team, reach out to Andrey Gurevich via email at [email protected] .
